Atypical Antipsychotic Lumateperone Effects on the Adrenal Gland With Possible Beneficial Effect of Quercetin Co-administration

Schizophrenia remains one of the most chronic and highly disabling mental disorders. Lumateperone is a recent FDA-approved atypical antipsychotic drug for the treatment of schizophrenia. However, the internal FDA pathologist raised concerns regarding pigment deposition associated with degeneration i...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Haroun, Hala, Ewida, Suzy Fayez, Mohamed, Wael M. Y., Bashandy, Manar Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279776/
https://www.ncbi.nlm.nih.gov/pubmed/34276400
http://dx.doi.org/10.3389/fphys.2021.674550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279776/
https://www.ncbi.nlm.nih.gov/pubmed/34276400
http://dx.doi.org/10.3389/fphys.2021.674550

Ejemplares similares